The ONCOSCREEN 1st Plenary Meeting was successfully held on 1-2 February in Paris. The project partners had constructive presentations and insightful discussions about the progress made within the 1st year of the project and the next steps for further development of the CRC screening technologies. Yiannis Gallos, Scientific Project Manager of I-SENSEGroup, presented the progress and main achievements in functional, non-functional requirements and compliant to standards and Secure-by-design system architecture.
I-Sense Group is the Technical Coordinator of the project, contributing – among other tasks – to the project’s quality and risk management activities and the shaping of the project’s data management plan and procedures together with CN-Lab research group of ICCS – NTUA.
The EU-funded ONCOSCREEN project aims to reverse this trend by promoting accurate, non-invasive, cost-effective screening tests based on new technologies and an increased awareness on the disease. Personalised approaches for screening are needed to consider genetic and other socioeconomic variables and environmental stressors. With this in mind, the project will develop a risk-based, population-level stratification methodology for CRC to account for genetic prevalence, socioeconomic status and other factors. Bringing together a 38-partner consortium, the project is in line with Horizon Europe’s Cancer Mission.
